Jus A, Gautier J, Villeneuve A, Jus K, Pires P, Gagnon-Binette M, Fortin C
Neuropsychobiology. 1978;4(5):305-13. doi: 10.1159/000117644.
The influence of amitriptyline on the plasma level of various neuroleptics was studied in 25 chronic schizophrenic patients. The study lasted 20 weeks. Patients were kept first 4 weeks on their former neuroleptic medication, with amitriptyline added for 12 subsequent weeks, and withdrawn during the last 4 weeks when only the neuroleptic medication was continued unchanged. The plasma level of neuroleptics was assayed by gas-liquid chromatography, once weekly throughout the study. The amitriptyline plasma level was also evaluated once weekly during the 12 weeks of its administration. The mean neuroleptic plasma values for each 4-week period were pooled together in three groups: aliphatic, piperdine and piperazine phenothiazine derivatives. Amitriptyline provoked some increase of the plasma level of all phenothiazine derivatives. This augmentation was significant only transitorily, however. The putative mechanisms of this neuroleptic tricyclic antidepressant interaction are discussed.
在25名慢性精神分裂症患者中研究了阿米替林对各种抗精神病药物血浆水平的影响。该研究持续了20周。患者最初4周维持原抗精神病药物治疗,随后12周添加阿米替林,在最后4周停药,仅继续使用原抗精神病药物且剂量不变。在整个研究过程中,每周一次通过气液色谱法测定抗精神病药物的血浆水平。在给予阿米替林的12周内,也每周一次评估其血浆水平。每4周期间的抗精神病药物血浆平均水平汇总为三组:脂肪族、哌啶和哌嗪类吩噻嗪衍生物。阿米替林使所有吩噻嗪衍生物的血浆水平有所升高。然而,这种升高仅在短期内具有显著性。讨论了这种抗精神病药物与三环类抗抑郁药相互作用的可能机制。